Search Results

There are 7809 results for: content related to: Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study

  1. You have free access to this content
    Hepatitis C genotype 4 therapy: increasing options and improving outcomes

    Liver International

    Volume 29, Issue s1, January 2009, Pages: 39–48, Sanaa M. Kamal

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01930.x

  2. Current prospects for interferon-free treatment of hepatitis C in 2012

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 38–45, Catherine AM Stedman

    Version of Record online : 19 DEC 2012, DOI: 10.1111/jgh.12028

  3. You have free access to this content
    The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report

    Liver International

    Volume 30, Issue 3, March 2010, Pages: 342–355, Nabil Antaki, Antonio Craxi, Sanaa Kamal, Rami Moucari, Schalk Van der Merwe, Samir Haffar, Adrian Gadano, Nizar Zein, Ching Lung Lai, Jean-Michel Pawlotsky, E. Jenny Heathcote, Geoffrey Dusheiko and Patrick Marcellin

    Version of Record online : 10 DEC 2009, DOI: 10.1111/j.1478-3231.2009.02188.x

  4. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2014 Update for Genotype 1

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 59–70, Drafting Committee for Hepatitis Management Guidelines, the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12272

  5. You have free access to this content
    Optimal therapy in hepatitis C virus genotypes 2 and 3 patients

    Liver International

    Volume 31, Issue s1, January 2011, Pages: 36–44, Salvatore Petta and Antonio Craxì

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02382.x

  6. You have free access to this content
    The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 749–758, Stefan Zeuzem, Peter Buggisch, Kosh Agarwal, Patrick Marcellin, Daniel Sereni, Hartwig Klinker, Christophe Moreno, Jean-Pierre Zarski, Yves Horsmans, Hongmei Mo, Sarah Arterburn, Steven Knox, David Oldach, John G. McHutchison, Michael P. Manns and Graham R. Foster

    Version of Record online : 23 FEB 2012, DOI: 10.1002/hep.24744

  7. You have free access to this content
    Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C

    Hepatology

    Volume 48, Issue 2, August 2008, Pages: 407–417, Stefan Zeuzem, Eric M. Yoshida, Yves Benhamou, Stephen Pianko, Vincent G. Bain, Daniel Shouval, Robert Flisiak, Vratislav Rehak, Mircea Grigorescu, Kelly Kaita, Patrick W. Cronin, Erik Pulkstenis, G. Mani Subramanian and John G. McHutchison

    Version of Record online : 9 MAY 2008, DOI: 10.1002/hep.22403

  8. Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1522–1531, Yan Xu, Wenqian Qi, Xu Wang, Ping Zhao, Yonggui Zhang, Qian Zhang, Shaoyou Qin and Jiangbin Wang

    Version of Record online : 12 DEC 2013, DOI: 10.1111/liv.12417

  9. You have free access to this content
    Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 969–983, A. G. Singal, A. K. Waljee, M. Shiffman, B. R. Bacon and P. S. Schoenfeld

    Version of Record online : 15 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04427.x

  10. You have free access to this content
    Systematic review: combination therapies for treatment-naïve chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 12, June 2008, Pages: 1187–1209, M. KUMAR and S. K. SARIN

    Version of Record online : 28 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03695.x

  11. Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients

    Hepatology Research

    Volume 41, Issue 12, December 2011, Pages: 1153–1168, Yasuteru Kondo, Yoshiyuki Ueno, Yuta Wakui, Masashi Ninomiya, Eiji Kakazu, Jun Inoue, Koju Kobayashi, Noriyuki Obara and Tooru Shimosegawa

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00878.x

  12. You have free access to this content
    Current and emerging antiviral treatments for hepatitis C infection

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 931–943, Joseph S. Doyle, Esther Aspinall, Danny Liew, Alexander J. Thompson and Margaret E. Hellard

    Version of Record online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04419.x

  13. Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

    Journal of Viral Hepatitis

    Volume 19, Issue 9, September 2012, Pages: 623–634, S. Pianko, S. Zeuzem, W.-L. Chuang, G. R. Foster, S. K. Sarin, R. Flisiak, C.-M. Lee, P. Andreone, T. Piratvisuth, S. Shah, A. Sood, J. George, M. Gould, P. Komolmit, S. Thongsawat, T. Tanwandee, J. Rasenack, Y. Li, M. Pang, Y. Yin, G. Feutren, I. M. Jacobson and for the B2202 Study Team

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01586.x

  14. Pegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis

    Hepatology Research

    Volume 43, Issue 12, December 2013, Pages: 1255–1263, Abdulrahman A. Aljumah and Mohammad Hassan Murad

    Version of Record online : 4 MAR 2013, DOI: 10.1111/hepr.12084

  15. Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 15, Issue 9, September 2008, Pages: 623–633, M. Gambarin-Gelwan and I. M. Jacobson

    Version of Record online : 10 JUL 2008, DOI: 10.1111/j.1365-2893.2008.01018.x

  16. You have free access to this content
    Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α

    Clinical Microbiology and Infection

    Volume 18, Issue 10, October 2012, Pages: 1033–1039, C. Scagnolari, S. Trombetti, A. Soldà, M. Milella, G. B. Gaeta, G. Angarano, G. Scotto, N. Caporaso, F. Morisco, R. Cozzolongo, G. Giannelli, M. Fasano, T. Santantonio and G. Antonelli

    Version of Record online : 22 DEC 2011, DOI: 10.1111/j.1469-0691.2011.03729.x

  17. You have free access to this content
    Review article: novel therapeutic options for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 10, May 2008, Pages: 866–884, E. CHOLONGITAS and G. V. PAPATHEODORIDIS

    Version of Record online : 12 FEB 2008, DOI: 10.1111/j.1365-2036.2008.03644.x

  18. Hepatitis C virus relapse was suppressed by long-term self-injection of low-dose interferon in patients with chronic hepatitis C after pegylated interferon plus ribavirin treatment

    Hepatology Research

    Volume 44, Issue 6, June 2014, Pages: 597–607, Tomoyuki Takashima, Hirayuki Enomoto, Toshiaki Ninomiya, Soo Ryang Kim, Hiroaki Okushin, Masahiko Sugano, Susumu Imoto, Yoshihiko Yano, Teruji Ooka, Yasushi Seo, Hiroshi Kasugai, Akira Muramatsu, Hisato Jomura, Soji Shimomura, Michiko Shindo, Hideji Nakamura, Nobuhiro Aizawa, Yoshinori Iwata, Masaki Saito, Hiroyasu Imanishi, Hiroko Iijma and Shuhei Nishiguchi

    Version of Record online : 30 MAY 2013, DOI: 10.1111/hepr.12153

  19. You have free access to this content
    New horizons in hepatitis C antiviral therapy with direct-acting antivirals

    Hepatology

    Volume 58, Issue 1, July 2013, Pages: 428–438, Alessio Aghemo and Raffaele De Francesco

    Version of Record online : 31 MAY 2013, DOI: 10.1002/hep.26371

  20. You have free access to this content
    Review article: HCV genotype 3 – the new treatment challenge

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 7, April 2014, Pages: 686–698, J. Ampuero, M. Romero-Gómez and K. R. Reddy

    Version of Record online : 20 FEB 2014, DOI: 10.1111/apt.12646